Utah Medical Products (NASDAQ:UTMD) Shares Cross Above Two Hundred Day Moving Average – Time to Sell?

Utah Medical Products, Inc. (NASDAQ:UTMD) shares crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $60.44 and traded as high as $64.38. Utah Medical Products shares last traded at $64.00, with a volume of 9,837 shares.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised shares of Utah Medical Products from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, February 25th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company has an average rating of “Hold”.

Utah Medical Products Stock Up 1.1%

The firm has a market cap of $204.80 million, a price-to-earnings ratio of 18.39 and a beta of 0.33. The firm has a 50 day moving average of $63.07 and a 200 day moving average of $60.44.

Utah Medical Products (NASDAQ:UTMD) last issued its quarterly earnings results on Thursday, January 29th. The medical instruments supplier reported $0.80 earnings per share (EPS) for the quarter. The firm had revenue of $9.04 million for the quarter. Utah Medical Products had a return on equity of 9.60% and a net margin of 29.30%.

Utah Medical Products Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 3rd. Investors of record on Tuesday, March 17th will be given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date is Tuesday, March 17th. Utah Medical Products’s payout ratio is presently 35.63%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Invesco Ltd. increased its stake in Utah Medical Products by 4.2% in the fourth quarter. Invesco Ltd. now owns 6,020 shares of the medical instruments supplier’s stock valued at $337,000 after purchasing an additional 243 shares in the last quarter. O Shaughnessy Asset Management LLC boosted its position in shares of Utah Medical Products by 2.3% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 14,903 shares of the medical instruments supplier’s stock worth $834,000 after purchasing an additional 337 shares in the last quarter. &PARTNERS boosted its position in shares of Utah Medical Products by 11.6% during the 4th quarter. &PARTNERS now owns 3,796 shares of the medical instruments supplier’s stock worth $212,000 after purchasing an additional 396 shares in the last quarter. Comerica Bank grew its stake in shares of Utah Medical Products by 435.6% in the 3rd quarter. Comerica Bank now owns 541 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 440 shares during the period. Finally, Cardinal Capital Management grew its stake in shares of Utah Medical Products by 1.9% in the 4th quarter. Cardinal Capital Management now owns 24,836 shares of the medical instruments supplier’s stock valued at $1,394,000 after buying an additional 459 shares during the period. 69.60% of the stock is owned by institutional investors.

About Utah Medical Products

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).